Breast Cancer: Adding Avastin Boosts Toxicity (CME/CE)

SAN ANTONIO (MedPage Today) -- Beleaguered bevacizumab (Avastin) has failed another test in breast cancer, a researcher said here.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news